Antiproliferative activity of conditioned medium from lymphocytes of neuroblastoma (NB) patient and inhibition with NB serum

Cancer Letters

Volumn 147, Issue 1-2, 1999, Pages 5-10

  Damle, Rajendra N ^a   Rao, Ranga ^b   Shastry, Padma ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b Armed Forces Med College 411 001 ^*  (India)

Author keywords

Activated lymphocytes; Conditioned medium; Glioblastoma; Neuroblastoma; Proliferation

Indexed keywords

PHYTOHEMAGGLUTININ; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CASE REPORT; CELL PROLIFERATION; CELLULAR IMMUNITY; CONDITIONED MEDIUM; CONTROLLED STUDY; DNA SYNTHESIS; GLIOBLASTOMA; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NEUROBLASTOMA; PERIPHERAL LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; SERUM; SUPERNATANT;

BLOOD PROTEINS; CELL DIVISION; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD, PRESCHOOL; CULTURE MEDIA, CONDITIONED; GLIOBLASTOMA; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; NEUROBLASTOMA; PHYTOHEMAGGLUTININS; TIME FACTORS;

EID: 0032726446     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00254-2     Document Type: Article

References (15)

1. Castleberry R.P. Clinical and biologic features in the prognosis and treatment of neuroblastoma. Curr. Opin. Oncol. 4:1992;116-123.
2. Cheung N.K., Medof M.E., Munn D. Immunotherapy with GD2 specific monoclonal antibodies. Evans A.E. Advances in Neuroblastoma Research 1. 1988;619-632 Liss, New York.
3. Cosgrove C., Cobbett P. Induction of temporally dissociated morphological and physiological differentiation of NIE-115 cells. Brain Res. Bull. 27:1991;53-58.
4. Hartmann O., Benhomou E., Beaujean F., Pico J., Kalifa C., Patte C., Flamant F., Lemerle J. Highdose busulfan and cyclophosphamide with autologous bone-marrow transplantation support in advanced malignancies in children: a phase II study. J. Clin. Oncol. 4:1986;1804-1810.
5. Hellstorm I.E., Hellstrom K.E., Pierce G.E., Bill A.H. Demonstration of cell bound humoral immunity against neuroblastoma cells. Proc. Natl. Acad. Sci. USA. 60:1968;1231-1238.
6. Ladisch S., Gillard B., Wong C., Ulsh L. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer Res. 43:1983;380-381.
7. Main E.K., Lampson L.A., Hart M.K., Korbluth J., Wilson D.B. Human neuroblastoma cells are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes. J. Immunol. 135:1985;242-246.
8. Montaldo P.G., Carbone R., Corrias M.V., Ferraris P.C., Ponzoni M. Synergistic differentiation promoting activity of interferon γ and tumor necrosis factor-α. Role of receptor regulation on human neuroblasts. J. Natl. Cancer Inst. 86:1994;1694-1700.
9. Mosmann T.J. Rapid colorimetric assay for cellular growth and survival. Application to proliferation and cytotoxic assay. J. Immunol. Methods. 65:1983;55-68.
10. Nitta T., Yagita H., Sato K., Okamura K. Involvement of CD56 (NKH-1/Leu 19 antigen) as an adhesion molecule in natural killer-target cell interaction. J. Exp. Med. 170:1989;1757-1761.
11. Perez E.M., Bellow J.L., Bendana A., Rabunal M.J., Gonzalez S., Abuin I., Noya M., Cadarso C. Detection of soluble interleukin-2 receptor in the serum of patients with non-Hogkin's lymphoma. Med. Clin. 111:1998;161-167.
12. Rossi A.R., Pericle F., Rashleigh S., Janie J., Djeu J.Y. Lysis of NB cell lines by human natural killer cells activated by interleukin-2 and interleukin-12. Blood. 83:1994;1323-1328.
13. Sakurai Y., Sawada T., Chung Y.S., Funae S.M. Identification and characterization of mobility stimulating factor secreted from pancreatic cancer cells: role in tumor invasion and metastasis. Clin. Exp. Metastasis. 15:1997;307-317.
14. Trinchieii G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-376.
15. Zier K.S., Pierson G.R., Brown V. Susceptibility of human neuroblastoma cell lines to cytotoxic T lymphocyte mediated lysis. J. Neuroimmunol. 28:1990;153-160.